PARAMEDIC 3 Trial

Studien extrahiert aus dem Podcast von Rob Mac Sweeney

• 2025PARAMEDIC-3Emergency & ResuscitationIn 6082 adults with out-of-hospital cardiac arrest, an intraosseous-first access strategy did not improve 30-day survival compared with intravenous-first access.
• 2018PARAMEDIC2Emergency & ResuscitationIn 8014 adults with out-of-hospital cardiac arrest, adrenaline improved 30-day survival compared with placebo, without more survivors free of severe disability.
• 2025IVIOEmergency & ResuscitationIn 1479 adults with out-of-hospital cardiac arrest, initial intraosseous access did not improve sustained ROSC compared with intravenous access.
• 2024VICTOREmergency & ResuscitationIn 1732 adults with out-of-hospital cardiac arrest, intraosseous-first access did not improve survival to discharge compared with intravenous access.